Jaano & Seekho – Know More. Think Deeper. Stay Ahead.
ज्ञान की पाठशाला
ALCOA vs. ALCOA++: Understanding Data Integrity in the Pharmaceutical Industry By :Dr. Dhriti Tupe, GxP Expert ® Data integrity is the backbone of compliance and quality in the pharmaceutical industry, ensuring that all data is accurate, reliable, and secure. Over the years, the concept of ALCOA has served as a guideline for maintaining data integrity. However,…
Explore 5 lucrative intellectual property career paths for science graduates. Discover how to leverage your scientific expertise in patent law, technology transfer, and IP management. Are you a science graduate looking to bridge the gap between innovation and law? The world of intellectual property (IP) offers a fascinating array of career opportunities that blend scientific…
Why Risk Assessment and Mitigation Controls Reporting is Mandatory for QA and How to Handle It? By :Dr. Dhriti Tupe, GxP Expert ® In the pharmaceutical industry, quality assurance (QA) isn’t just about meeting regulatory requirements—it’s about safeguarding patient health and ensuring that every product delivered is safe, effective, and of the highest quality. A critical…
Cluster Development Programme (CDP) & Data Governance: Why It’s Mandatory and How to Handle It in the Pharmaceutical Industry By :Dr. Dhriti Tupe, GxP Expert ® In the rapidly evolving landscape of the pharmaceutical industry, the integration of technology and data has become paramount. Among the many initiatives that have gained traction, the Cluster Development Programme…
Extractables and leachables: definitions, differences & facts Extractables and leachables are contaminants that are causing biopharmaceutical manufacturers headaches, as they can lead to impurities of highly valuable drug products. The FDA defines the two terms as follows: Extractables are compounds that can be extracted from the container closure system when in the presence of a solvent Leachables…
Visible Particles in Parenteral Drug Products: A Review of Current Safety Assessment Practice Visible particles (VPs) in parenteral drug products (PDPs) pose significant safety risks to patients and are a critical quality concern in the pharmaceutical industry. Despite technological advancements in particle detection and stringent regulatory controls, contamination with VPs remains a challenge. This review…
Introduction: Clinical trials are essential for evaluating the safety and efficacy of new medical treatments. They provide a rigorous framework for testing hypotheses and drawing reliable conclusions. However, statistics plays a crucial role in ensuring that clinical trial results are accurate, unbiased, and meaningful. In this blog post, we will explore the significance of statistics…
Why DQ, IQ, OQ, PQ Are Mandatory in Quality Assurance: Why It’s Essential and How to Handle It? By :Dr. Dhriti Tupe, GxP Expert ® In the pharmaceutical and life sciences industries, ensuring that equipment, systems, and processes are properly designed, installed, and operated is not just best practice—it’s a regulatory requirement. The key tools used…
Cleaning Validation and Verification Reporting: A Mandatory QA Requirement By :Dr. Dhriti Tupe, GxP Expert ® Introduction In pharmaceutical manufacturing, ensuring the quality and safety of products is paramount. One critical aspect of quality assurance (QA) is cleaning validation and verification, which confirms the effectiveness of cleaning processes in removing residues and contaminants. Why is Cleaning…
Handling Elemental Impurities Risk Assessments in Pharmaceuticals By :Dr. Dhriti Tupe, GxP Expert ® A Comprehensive Guide Elemental impurities in pharmaceuticals can be harmful to patients. Regulatory agencies have set guidelines to manage these risks through proper assessments. In this blog, we’ll explore the essentials of elemental impurities risk assessments, including key considerations, best practices,…
